About Yokohama City University Medical Center ( Site 0706)
公立大学法人横浜市立大学附属市民総合医療センターは、神奈川県横浜市南区浦舟町にある横浜市立大学附属の大学病院である。神奈川県災害医療拠点病院の一つ。略称は「市大センター病院」。現在でも「十全医院」という古い略称で呼ばれることがある。
Clinical Trials at Yokohama City University Medical Center ( Site 0706)
During the past decade, Yokohama City University Medical Center ( Site 0706) conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Yokohama City University Medical Center ( Site 0706)"
#1 collaborator was "Ministry of Health, Labour and Welfare, Japan" with 3 trials as a collaborator, "Taiho Pharmaceutical Co., Ltd." with 1 trials as a collaborator and "Yakult Honsha Co., LTD" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Yokohama City University Medical Center ( Site 0706)
According to Clinical.Site data, the most researched conditions in "Yokohama City University Medical Center ( Site 0706)" are
"Prostatic Neoplasms" (3 trials), "Colorectal Neoplasms" (1 trials), "Gastric Cancer" (1 trials) and "Rectal Neoplasms" (1 trials). Many other conditions were trialed in "Yokohama City University Medical Center ( Site 0706)" in a lesser frequency.
Clinical Trials Intervention Types at Yokohama City University Medical Center ( Site 0706)
Most popular intervention types in "Yokohama City University Medical Center ( Site 0706)" are "Drug" (5 trials), "Biological" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Pembrolizumab" (3 trials), "Enzalutamide" (2 trials), "Placebo" (2 trials), "Prednisone" (2 trials) and "5FU+l-leucovorin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Yokohama City University Medical Center ( Site 0706)
The vast majority of trials in "Yokohama City University Medical Center ( Site 0706)" are
3 trials for "All" genders and 3 trials for "Male" genders.
Clinical Trials Status at Yokohama City University Medical Center ( Site 0706)
Currently, there are NaN active trials in "Yokohama City University Medical Center ( Site 0706)".
undefined are not yet recruiting,
undefined are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Yokohama City University Medical Center ( Site 0706),
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Yokohama City University Medical Center ( Site 0706), 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".